HCC.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 45
What's happening
One to three months ago
-
HCC has been serving Canadian consumers since 2001.Some support1 report
-
The Texas Higher Education Coordinating Board is tracking the performance of HCC, which operates within the state of Texas.Some support1 report
-
HCC governs planning in Hobart.Some support1 report1 development inside
-
The RAYS, in partnership with HCC, have unveiled a shared development plan for a mixed-use campus in the Tampa area.Some support1 report
-
Pughs joined the HCC Hill Ram, a farm located in Trecastle, Powys.Some support1 report
-
Required filings regarding institutional purchases of HCC were made to the Securities and Exchange Commission, alongside Citigroup providing research reports on the company's stock.Some support1 report
-
Muzastotug is being tested for efficacy in HCC, and a clinical collaboration has been initiated for dosing trials.Some support1 report
-
Moleculin Biotech, Inc. announced that Annamycin showed efficacy against HCC models, and Waldemar Priebe serves on the Scientific Advisory Board.Some support3 reports
-
The Council manages the grounds and services related to HCC.Well supported4 reports
Gone quiet
No new reports in 90+ days-
MAIA Biotechnology is developing immunotherapies for HCC. The FDA granted Orphan Drug Designation for this treatment, and Pinato is a leading clinician scientist in the field.Speculative1 report
-
Cyclacel is highlighting research into Fibrolamellar Cancer (FLC), noting that FLC is frequently misdiagnosed as Hepatocellular Carcinoma (HCC).Speculative1 report
-
Tvardi Therapeutics is developing drugs targeting STAT3 for Idiopathic Pulmonary Fibrosis and HCC, and received FDA orphan drug designation for the HCC indication.Some support2 reports
-
Can-Fite BioPharma filed a registration statement with the SEC (Bangladesh) and announced a stock offering with HCC acting as the exclusive placement agent.Some support1 report
-
HCC compares estimates to actual results via Zacks Earnings ESP on July 30, 2025.Some support1 report
-
FDA approved LOQTORZI treatment for NPC, following findings that CHS-114 depletes immunosuppressive Treg cells.Some support1 report
-
Tempest Therapeutics developed HCC therapeutics, obtaining FDA and EMA designations and initiating pivotal trials in China.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around HCC this week
News at the entities that move HCC most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves HCC
-
Wendy Hensel StructuralWendy Hensel and Hayashi kicked off the Direct2UH venture.Moves HCC
-
European Medicines Agency StructuralGlenn attended a congress in Amsterdam and participated in a panel with an official from the European Medicines Agency.Moves HCC
-
local government StructuralGovernor suspended local authority functions in Kandy District on October 1, 2026.Moves HCC
-
Securities and Exchange Commission StructuralNYSE and Nasdaq plan to expand trading hours and file updated rules with the SEC.Moves HCC
-
Citigroup OperationalCitigroup upgraded Next plc to a buy rating, while Santander and Morgan Stanley also issued rating updates on the company.Moves HCC
Connections
The 24 strongest of 45, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Belleville Structural
Belleville utilizes HCC as a primary care provider resource for registration and patient linking services in Ontario.
-
Wendy Hensel Structural
Wendy Hensel holds an oversight role during HCC's leadership transition.
-
European Medicines Agency Structural
The EMA provides pivotal guidance and evaluation for HCC's product program, establishing a regulatory dependency.
-
FDA Structural
The company HCC operates under the formal regulatory oversight and guidance of the FDA for market entry in the United States.
-
Hollywood Walk of Fame Structural
HCC manages the intellectual property rights for the Hollywood Walk of Fame landmark.
-
Can-Fite BioPharma (Israel) Transactional
HCC functions as the exclusive placement agent for Can-Fite BioPharma's drug Namodenoson.
-
local government Structural
HCC seeks and receives technical support from the local government ministry.
-
Harare Structural
HCC functions as a service provider, managing specific city services within the operational boundaries of Harare.
Show all 24 connections
-
Securities and Exchange Commission Structural
HCC is subject to mandatory regulatory filings and oversight by the U.S. Securities and Exchange Commission.
-
Hobart Structural
HCC holds a formal planning and governance function within the location of Hobart.
-
Tempest Operational
Tempest is developing therapeutics specifically targeting the HCC disease area.
-
Tampa Shared context
The company's operations are situated within the city's economic sphere, benefiting from local development and infrastructure.
-
Citigroup Operational
Citigroup provides financial research reports on HCC's stock.
-
Yorke Peninsula Shared context
HCC operates as a college focused on agricultural education within the geographical area of Yorke Peninsula.
-
Indonesia Operational
Indonesia and HCC have a cooperation agreement focused on the creative industry.
-
cheviot Structural
A potential structural link was formed when Pugh joined HCC.
-
RAYS Operational
RAYS and HCC are collaborating on a shared development plan for a mixed-use campus.
-
Madagascar Operational
The company's operational viability is impacted by the political instability and judicial crisis in the country of operation.
-
Los Angeles Shared context
HCC is located in California, which encompasses Los Angeles.
-
East Asia Shared context
HCC incidence and mortality are reported as highest in East Asia.
-
Uttarakhand Operational
HCC staff provided assistance during a tunnel recovery operation in Uttarakhand.
-
Texas Shared context
HCC operates within the jurisdiction of the state of Texas.
-
Texas Higher Education Coordinating Board Mentioned together
The Texas Higher Education Coordinating Board tracks the performance of HCC.
-
Copper Coast Shared context
HCC operates within the geographical context of Copper Coast.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
6 events- The Texas Higher Education Coordinating Board is tracking the performance of HCC, which operates within the state of Texas.
- HCC governs planning in Hobart.
- The RAYS, in partnership with HCC, have unveiled a shared development plan for a mixed-use campus in the Tampa area.
- Pughs joined the HCC Hill Ram, a farm located in Trecastle, Powys.
- Required filings regarding institutional purchases of HCC were made to the Securities and Exchange Commission, alongside Citigroup providing research reports on the company's stock.
- Muzastotug is being tested for efficacy in HCC, and a clinical collaboration has been initiated for dosing trials.
June 2026
9 events- Moleculin Biotech, Inc. announced that Annamycin showed efficacy against HCC models, and Waldemar Priebe serves on the Scientific Advisory Board.
- The Council manages the grounds and services related to HCC.
- MAIA Biotechnology is developing immunotherapies for HCC. The FDA granted Orphan Drug Designation for this treatment, and Pinato is a leading clinician scientist in the field.
- Cyclacel is highlighting research into Fibrolamellar Cancer (FLC), noting that FLC is frequently misdiagnosed as Hepatocellular Carcinoma (HCC).
- Tvardi Therapeutics is developing drugs targeting STAT3 for Idiopathic Pulmonary Fibrosis and HCC, and received FDA orphan drug designation for the HCC indication.
- Can-Fite BioPharma filed a registration statement with the SEC (Bangladesh) and announced a stock offering with HCC acting as the exclusive placement agent.
- HCC compares estimates to actual results via Zacks Earnings ESP on July 30, 2025.
- FDA approved LOQTORZI treatment for NPC, following findings that CHS-114 depletes immunosuppressive Treg cells.
- Tempest Therapeutics developed HCC therapeutics, obtaining FDA and EMA designations and initiating pivotal trials in China.